Alzheimer’s disease develops when two abnormal proteins gradually build up in the brain, destroying nerve cells over a period of years or even decades before symptoms appear. There isn’t a single cause. For most people, it results from a combination of age, genetics, and lifestyle factors that interact over a lifetime. About 1 in 9 people aged 65 and older have Alzheimer’s, and the risk climbs steeply with each additional decade of life.
What Happens Inside the Brain
The disease begins with two proteins that go wrong. The first is beta-amyloid, a sticky fragment that normally gets cleared away by the brain. In Alzheimer’s, too much of a particularly long form of this protein accumulates between brain cells. These fragments clump together into small toxic clusters called oligomers, which interfere with how neurons communicate. Over time, the oligomers merge into dense, insoluble plaques that sit between cells, blocking signals and triggering inflammation.
The second protein, called tau, normally acts like scaffolding inside neurons, helping transport nutrients along the cell’s internal skeleton. When tau becomes misshapen, it collapses that skeleton and forms tangled threads inside the cell. Without functioning tau, neurons can no longer move essential materials where they’re needed, and communication between cells breaks down further.
The brain doesn’t passively accept this damage. It launches an immune defense, attempting to clear the toxic proteins and repair injured cells. The brain’s primary immune cells initially try to engulf and remove amyloid buildup. But when the assault is chronic rather than temporary, these immune cells shift from helpful to harmful. They enter a state of sustained activation that actually accelerates damage, releasing inflammatory molecules that poison surrounding neurons and strip away the connections between them. This chronic inflammation is now understood to actively drive the disease forward, not just react to it. As plaques, tangles, and inflammation overwhelm the brain’s repair systems, neurons die in large numbers and the brain physically shrinks.
The Role of Genetics
Genes influence Alzheimer’s risk in two distinct ways, depending on whether the disease appears early or late in life.
Late-Onset Alzheimer’s
The vast majority of cases develop after age 65, and the strongest known genetic risk factor is a gene variant called APOE e4. About 15% to 25% of the population carries one copy of this variant, and 2% to 5% carry two copies. Having one copy raises your risk; having two copies raises it significantly more and is associated with developing symptoms at a younger age. But APOE e4 is a risk factor, not a guarantee. Many carriers never develop the disease, and many people who get Alzheimer’s don’t carry the variant at all.
Early-Onset Alzheimer’s
A small fraction of cases, typically striking in a person’s 40s or 50s, are caused by rare inherited mutations in one of three specific genes. More than 200 of these mutations have been identified. They follow an autosomal dominant pattern, meaning a child of someone with the mutation has a 50% chance of inheriting it. If inherited, the mutation virtually guarantees the person will develop the disease. These cases account for a tiny share of all Alzheimer’s diagnoses, but studying them has been critical to understanding how the disease works in everyone.
Age: The Biggest Risk Factor
Getting older doesn’t cause Alzheimer’s, but it is the single strongest predictor. The protein buildup, immune dysfunction, and loss of the brain’s ability to repair itself all accumulate with time. Changes in blood flow, energy metabolism, and the brain’s waste-clearing systems that come with aging create an environment where amyloid and tau are more likely to take hold. This is why the disease is rare before 65 and increasingly common after.
Cardiovascular Health and the Brain
The connection between heart health and brain health is one of the most actionable findings in Alzheimer’s research. High blood pressure damages the small blood vessels that supply the brain regions responsible for thinking and memory. People with hypertension in midlife are more likely to show biological markers of Alzheimer’s in their spinal fluid later on, and greater blood pressure variability over time is linked to higher dementia risk.
The flip side is encouraging. Research from Johns Hopkins found that people who took blood pressure medications were roughly half as likely to develop Alzheimer’s as those who didn’t, with certain types of blood pressure drugs reducing risk by as much as 75%. This doesn’t mean medication alone prevents the disease, but it underscores how profoundly vascular health shapes brain health over the long term.
Lifestyle and Environmental Risk Factors
A landmark report from The Lancet Commission on dementia prevention identified 14 modifiable risk factors that collectively account for a meaningful share of dementia cases worldwide. These span the entire lifespan:
- Early life: Less education
- Midlife: Hearing loss, high blood pressure, obesity, traumatic brain injury, high cholesterol
- Later life: Smoking, depression, physical inactivity, diabetes, excessive alcohol consumption, air pollution, social isolation, untreated vision loss
None of these individually “causes” Alzheimer’s the way a single gene mutation can. Instead, each one nudges the brain toward vulnerability. Physical inactivity and diabetes, for example, both reduce blood flow and energy supply to neurons. Depression and social isolation appear to affect the brain’s resilience and its ability to compensate for early damage. Hearing and vision loss reduce cognitive stimulation, which may accelerate decline in a brain already under stress.
Air pollution has emerged as a surprisingly significant factor. Long-term exposure to fine particulate matter (the tiny particles from vehicle exhaust, industrial emissions, and wildfires) is associated with a measurable increase in dementia risk. These particles are small enough to reach the brain, where they can trigger the same kind of chronic inflammation that drives Alzheimer’s progression from within.
Why Some People Get It and Others Don’t
The honest answer is that researchers still can’t fully explain why one person develops Alzheimer’s and another with a similar profile doesn’t. The concept of “cognitive reserve” offers a partial explanation: people who have spent a lifetime building dense neural networks through education, complex work, social engagement, and physical activity seem better able to tolerate the protein buildup before symptoms appear. Their brains have more backup pathways.
What’s clear is that Alzheimer’s is rarely the result of one thing going wrong. It’s typically a convergence: genetic susceptibility meets decades of vascular wear, compounded by lifestyle factors and the brain’s declining ability to clean up toxic proteins with age. The protein changes can begin 15 to 20 years before any memory problems surface, which is why midlife choices about exercise, blood pressure, hearing, and social connection carry so much weight. By the time symptoms appear, the disease has been building for a long time.